Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Global SYMPLICITY Registry (GSR) DEFINE

NCT: NCT01534299 · RECRUITING

NCT IDNCT01534299
StatusRECRUITING
Start Date2012-02
Completion2031-12

Brief Summary

This is a prospective, multi-center, single-arm, non-interventional and open-label registry. The purpose of the registry is to document the long-term safety and effectiveness of renal denervation in a real world patient population with hypertension GSR DEFINE is the continuation of the Global SYMPLICITY Registry and collectively will enroll approximately 5000 patients with hypertension who undergo the renal denervation procedure, from over 300 sites worldwide. Subjects included in GSR DEFINE will be followed for a minimum of 1 year and up to 5 years post-procedure. Patients with uncontrolled hypertension will be enrolled in accordance with the inclusion criteria specified in the protocol.

Frequently Asked Questions

What is Global SYMPLICITY Registry (GSR) DEFINE?

Global SYMPLICITY Registry (GSR) DEFINE is a clinical trial registered under NCT01534299. Current status: RECRUITING.

What is the status of NCT01534299?

The current status of NCT01534299 (Global SYMPLICITY Registry (GSR) DEFINE) is: RECRUITING.

When did Global SYMPLICITY Registry (GSR) DEFINE start?

Global SYMPLICITY Registry (GSR) DEFINE started on 2012-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.